Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study
- PMID: 28932372
- PMCID: PMC5596191
- DOI: 10.22088/cjim.8.3.196
Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study
Abstract
Background: Migraine is a common type of headache. Sometimes adequate pain relief is not achieved by conventional treatments. Acupuncture and botulinum toxin-A injection are known as non-pharmacological interventions for this purpose. The aim of this research was to compare the effect of acupuncture with botulinum toxin-A injection and pharmacological treatment in controlling chronic migraine.
Methods: This clinical trial was conducted on patients with chronic migraine in the North of Iran during 2014-2015. Eligible patients were randomly allocated to groups receiving acupuncture (A) or botulinum toxin A (B) and controls (C) by designed quadripartite blocks. All patients were evaluated at baseline, one, two and three months after treatment using visual analogue scale (VAS) score and other parameters. The analysis of data was performed in SPSS software Version 19.
Results: One hundred fifty patients (48 males and 102 females) completed this study. During the 3- month study, the pain severity significantly diminished in three groups (P=0.0001), with greater reduction in group A (P=0.0001). The number of days per month with migraine, absence from work and the need for medication significantly decreased in three groups at 3 times of evaluation (p<0.05) with fewer side effects in group A (P=0.021).
Conclusion: Acupuncture, botulinum toxin-A injection and pharmacological treatment have beneficial effects on chronic migraine; however, acupuncture showed more effectiveness and fewer complications.
Keywords: Acupuncture; Botulinum Toxin-A; Chronic; Migraine; Pain Management.
Conflict of interest statement
The authors declared no conflict of interest
Figures





Similar articles
-
Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.Headache. 2003 Sep;43(8):853-60. doi: 10.1046/j.1526-4610.2003.03163.x. Headache. 2003. PMID: 12940806
-
Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.JAMA. 2012 Apr 25;307(16):1736-45. doi: 10.1001/jama.2012.505. JAMA. 2012. PMID: 22535858
-
Botulinum toxin type A and acute drug costs in migraine with triptan overuse.Can J Neurol Sci. 2010 Sep;37(5):588-94. doi: 10.1017/s031716710001074x. Can J Neurol Sci. 2010. PMID: 21059503
-
Botulinum toxin in migraine prophylaxis.J Neurol. 2004 Feb;251 Suppl 1:I8-11. doi: 10.1007/s00415-004-1103-y. J Neurol. 2004. PMID: 14991336 Review.
-
Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis.Health Technol Assess. 2004 Nov;8(48):iii, 1-35. doi: 10.3310/hta8480. Health Technol Assess. 2004. PMID: 15527670 Review.
Cited by
-
Classic Chinese Acupuncture versus Different Types of Control Groups for the Treatment of Chronic Pain: Review of Randomized Controlled Trials (2000-2018).Evid Based Complement Alternat Med. 2019 Dec 4;2019:6283912. doi: 10.1155/2019/6283912. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31885655 Free PMC article. Review.
-
Acupuncture and Its Role in the Treatment of Migraine Headaches.Neurol Ther. 2020 Dec;9(2):375-394. doi: 10.1007/s40120-020-00216-1. Epub 2020 Oct 1. Neurol Ther. 2020. PMID: 33001385 Free PMC article. Review.
-
Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis.J Neurol. 2024 Sep;271(9):5762-5777. doi: 10.1007/s00415-024-12512-z. Epub 2024 Jun 23. J Neurol. 2024. PMID: 38910144
-
Efficacy of acupuncture for migraine prophylaxis: a trial sequential meta-analysis.J Neurol. 2021 Nov;268(11):4128-4137. doi: 10.1007/s00415-020-10178-x. Epub 2020 Aug 24. J Neurol. 2021. PMID: 32839839
-
Acupuncture for chronic nonpulsatile tinnitus: A randomized clinical trial.Caspian J Intern Med. 2018 Winter;9(1):38-45. doi: 10.22088/cjim.9.1.38. Caspian J Intern Med. 2018. PMID: 29387318 Free PMC article.
References
-
- Delfan B, Bahmani M, Hassanzadazar H, Saki K, Rafieian-Kopaei M. Identification of medicinal plants affecting on headaches and migraines in Lorestan Province, West of Iran. Asian Pac J Trop Med. 2014;7:S376–9. - PubMed
-
- Headache Classification Committee of the International Headache Society (HIS) The International Classification of Headache Disorders: 3rd edition (beta version) Cephalalgia. 2013;33:629–808. - PubMed
LinkOut - more resources
Full Text Sources